Fulgent Genetics Total Non-Operating Income/Expense 2015-2024 | FLGT

Fulgent Genetics total non-operating income/expense from 2015 to 2024. Total non-operating income/expense can be defined as the sum of all non-operating expenses for the given industry.
Fulgent Genetics Annual Total Non-Operating Income/Expense
(Millions of US $)
2024 $22
2023 $21
2022 $5
2021 $1
2020 $2
2019 $1
2018 $0
2017 $0
2016 $-5
2015 $0
2014 $0
Fulgent Genetics Quarterly Total Non-Operating Income/Expense
(Millions of US $)
2024-12-31 $8
2024-09-30 $-1
2024-06-30 $8
2024-03-31 $8
2023-12-31 $6
2023-09-30 $7
2023-06-30 $5
2023-03-31 $4
2022-12-31 $3
2022-09-30 $1
2022-06-30 $1
2022-03-31 $0
2021-12-31 $0
2021-09-30 $0
2021-06-30 $1
2021-03-31 $0
2020-12-31 $1
2020-09-30 $0
2020-06-30 $0
2020-03-31 $0
2019-12-31 $0
2019-09-30 $0
2019-06-30 $0
2019-03-31 $0
2018-12-31 $0
2018-09-30 $0
2018-06-30 $0
2018-03-31 $0
2017-12-31 $0
2017-09-30 $0
2017-06-30 $0
2017-03-31 $0
2016-12-31 $0
2016-09-30 $0
2016-06-30 $-5
2016-03-31 $0
2015-12-31
2015-09-30
2015-06-30
2014-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.613B $0.283B
Fulgent Genetics, Inc. provides genetic testing services to physicians with clinically actionable diagnostic information. The company's technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process which serves primarily to hospitals and medical institutions. Fulgent Genetics is headquartered in Temple City, California.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $39.281B 54.26
Hims & Hers Health (HIMS) United States $12.358B 128.40
Tempus AI (TEM) United States $10.796B 0.00
Inspire Medical Systems (INSP) United States $4.614B 72.09
IRhythm Technologies (IRTC) United States $4.399B 0.00
Privia Health (PRVA) United States $3.055B 208.83
Enovis (ENOV) United States $2.089B 11.65
Clover Health Investments (CLOV) United States $1.773B 0.00
Schrodinger (SDGR) United States $1.765B 0.00
Phreesia (PHR) United States $1.531B 0.00
Azenta (AZTA) United States $1.296B 60.21
Omnicell (OMCL) United States $1.286B 22.69
10x Genomics (TXG) United States $1.161B 0.00
Butterfly Network (BFLY) United States $0.581B 0.00
Talkspace (TALK) United States $0.515B 154.00
Veradigm (MDRX) United States $0.455B 0.00
Standard BioTools (LAB) United States $0.441B 0.00
TruBridge (TBRG) United States $0.395B 875.67
Claritev (CTEV) United States $0.353B 0.00
Health Catalyst (HCAT) United States $0.315B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.212B 0.00
Nyxoah SA (NYXH) Belgium $0.204B 0.00
EUDA Health Holdings (EUDA) Singapore $0.151B 0.00
Pulmonx (LUNG) United States $0.148B 0.00
American Well (AMWL) United States $0.113B 0.00
MDxHealth SA (MDXH) Belgium $0.087B 0.00
CareCloud (CCLD) United States $0.086B 3.27
Retrieve Medical Holdings (RMHI) United States $0.083B 0.00
111 (YI) China $0.068B 0.00
P3 Health Partners (PIII) United States $0.061B 0.00
Outset Medical (OM) United States $0.059B 0.00
HeartBeam (BEAT) United States $0.058B 0.00
Zepp Health (ZEPP) Netherlands $0.043B 0.00
Zhongchao (ZCMD) China $0.029B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.021B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
MSP Recovery (MSPR) United States $0.016B 0.00
Streamline Health Solutions (STRM) United States $0.011B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Healthcare Triangle (HCTI) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Precipio (PRPO) United States $0.010B 0.00
Movano (MOVE) United States $0.006B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00